ICON Announces Clinical Research partnership with DuPage Medical Group
ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part of ICON Site and...
Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre
Boehringer Ingelheim, the world’s second largest animal health company, has been boosting its investment in China by expanding the Asian Veterinary Research & Development...
Sumitomo Dainippon Pharma Announces Joint Research Agreement with MMV for Identification of Antimalarial Candidate Compounds
Sumitomo Dainippon Pharma Co., Ltd. announced that it has signed an agreement with Medicines for Malaria Venture (Geneva, Switzerland; "MMV") on joint research aimed at...
Prothena Announces Global Neuroscience R&D Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan...
Praluent extensively reduces risk of cardiovascular events in high-risk patients, and was associated with lower death rate
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse...
Business Finland provides €3 Million Loan to Forendo Pharma for Developing Novel Treatments for Endometriosis
Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a €3 million R&D loan...
Italian pharmaceutical R & D excellence presented at the 33rd Congress of the European Association of Urology
Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative anti-cancer cell-directed paclitaxel-hyaluronan bioconjugate...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...